India reports 7,151 active Covid-19 cases; six new deaths in last 24 hrs
New Delhi, June 12 (UNI) India's total number of Covid-19 cases has reached 7,151 as of 8 AM on Thursday, according to the Ministry of Health and Family Welfare.
In the past 24 hours, 33 new infections have been confirmed, though case data from West Bengal is still awaited.
Additionally, six new deaths linked to Covid-19 were reported in the last 24 hours: three from Kerala, two from Karnataka, and one from Maharashtra. These bring the total number of Covid-related deaths in 2025 to 74.
On a positive note, more than 8,000 individuals have recovered from the virus so far this year.
While several states have reported modest increases in active cases, Kerala remains the worst affected, with 2,223 active infections as of Thursday.
Other states with relatively high caseloads include Gujarat, West Bengal, Delhi, and Maharashtra, based on data from the national COVID-19 dashboard.
Health authorities attribute the current rise in infections to new Omicron sub-variants including JN.1, NB.1.8.1, LF.7, and XFC. These strains are noted for their high transmissibility but are causing milder illness compared to earlier variants.
The World Health Organisation (WHO) has classified them as "Variants Under Monitoring", indicating that while they are not currently a serious threat, their progress should be observed closely.
Covid-19, caused by the SARS-CoV-2 virus, has now transitioned into a seasonal pattern similar to the flu. Though no longer considered an emergency, the virus continues to circulate and may pose risks, especially to vulnerable populations.
UNI AJ ARN
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
9 minutes ago
- NDTV
After Covid-19, Hepatitis A Outbreak in Kerala: What Are The Symptoms And Causes
Kerala is currently witnessing a sharp rise in hepatitis A infections in Avoly and nearby panchayats in Muvattupuzha, around 47 km from the city. The Health authorities have confirmed around 50 cases so far. The first case was reported on May 30. The incubation period for hepatitis A is two to six weeks, therefore, health authorities expect more cases to surface in the coming days. Most infected individuals attended a wedding at Nadukkara ward in Avoly panchayat on May 3. The authorities suspect that contaminated food and water served at the function may have triggered the outbreak. Around 150 people from Avoly, Manjalloor and Arakuzha panchayats in Muvattupuzha and Idukki and Alappuzha districts attended the event. Hepatitis A: Causes, symptoms and more Hepatitis A is a highly contagious liver infection that usually spreads from contaminated food or water or close contact with an infected person or object. Hepatitis viruses cause liver inflammation and affect your liver's ability to function. What are the symptoms of hepatitis A? Hepatitis A symptoms can include: Fever Loss of appetite Diarrhea Tiredness and weakness Abdominal discomfort Dark-coloured urine Jaundice Joint pain Itchy skin Not everyone who is infected will have all the symptoms. Symptoms are typically mild and go away in a few weeks. However, in some cases, symptoms can last for several months and even lead to severe illness. How to prevent Vaccination against hepatitis A is one of the most effective ways to prevent it. The vaccine is typically given in two shots. The first shot is followed by a booster shot. Other preventive measures include: Avoid raw and undercooked meat and fish Wash fruits and vegetables thoroughly and avoid pre-cut fruits and vegetables. Practice good hygiene, especially after using the toilet or changing a diaper and before preparing food or eating Ensure adequate supplies of safe drinking water Use of safer sex practices According to the World Health Organisation, most individuals recover fully from hepatitis A with lifelong immunity. However, a very small proportion of people infected with hepatitis A could die from fulminant hepatitis.
Time of India
14 minutes ago
- Time of India
Japan introduces universal artificial blood that helps save lives; here's how
Source: The Japan Times Japanese scientists have developed a universal artificial blood substitute that can revolutionize global healthcare and address critical blood shortage challenges. Artificial blood is an invention, which serves as a substitute for real blood. With the World Health Organisation (WHO) highlighting a global blood shortage, this innovation could play a very crucial role in saving lives during trauma, surgeries, emergencies, and other medical procedures, if proven successful. If the clinical trials prove successful, Japan could become the first-country to deploy artificial blood for real-world medical care by 2030. Japan creates virus-free artificial blood that can be stored for years Professor Hiromi Sakai at Nara Medical University has pioneered this approach, creating stable, virus-free artificial red blood cells that eliminate the need for blood type matching. According to The Japan Times, artificial red blood cells are produced by extracting hemoglobin, which carries oxygen, from donated blood and wrapping it with an artificial lipid membrane, according to the team. The artificial cells have a purplish color, unlike the common red color of blood, as they are made in a way that they do not oxidize until they are used The artificial blood technology centers on hemoglobin vesicles, small artificial blood cells that extract hemoglobin, the oxygen-carrying molecule, from expired donor blood and encase it in protective shells. Artificial blood offers several benefits over traditional blood donations. It eliminates the need for compatible testing, making it very useful in emergency situations, and can be stored at room temperature for up to two years, far exceeding the short shelf life of donated blood. Revolutionizing global healthcare This technology could improve healthcare by eliminating the compatibility issues and blood shortages especially in remote areas where blood storage and matching are challenging. Unlike donated blood, these artificial cells have no blood type, eliminating the need for compatibility testing and making them valuable in emergencies. It represents a significant humanitarian breakthrough, promising to ensure blood availability anywhere, anytime, and transforming global healthcare systems. Trial design The trial will initially focus on testing safety before moving to broader performance and efficacy targets. It will administer 100 to 400 milliliters of artificial blood on volunteers. The research represents rapid progress of Japan's artificial blood development program. Their program began with small-scale studies demonstrating that these tiny artificial cells could safely deliver oxygen as normal blood cells do. Also read | 3,500-year-old grave reveals: change in bronze age history around 1500 BC in Central Europe
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
India reports one Covid-19 death in 24 hrs, active cases dip to 7,131
India recorded one Covid-19 death and reported a dip in active cases to 7,131, marking the first decline during the current outbreak; Kerala remains worst-affected New Delhi India's active Covid-19 case tally fell for the first time during this outbreak to 7,131, with 23 fewer cases reported in the last 24 hours, according to the latest data from the Ministry of Health and Family Welfare released on Friday. One death was also recorded during the same period. The only reported fatality was that of an elderly man in Kerala. New subvariants drive surge amid first dip in weekly trend Kerala tops active cases; Gujarat sees highest daily spike Kerala continues to top the chart among states, reporting 2,055 active Covid-19 cases. Gujarat witnessed the most—77 fresh active cases—pushing its active tally to 1,358. Active cases in Delhi fell to 714. State Active Cases New Cases (Last 24 Hours) Deaths (Last 24 Hours) Kerala 2,055 -110 1 Maharashtra 629 14 0 Gujarat 1,358 77 0 Delhi 714 -17 0 West Bengal 747 Karnataka 395 -72 0 Tamil Nadu 220 -11 0 Experts advise targeted boosters, not mass campaigns Health experts have recommended against launching a mass booster vaccination drive in response to the recent surge in Covid-19 cases, instead advocating a targeted approach for high-risk populations. This includes the elderly, immunocompromised individuals, and people with chronic conditions. Emphasis on precautions, testing and early care for high-risk groups They have also underscored the continued importance of following Covid-appropriate behaviour, such as wearing masks, maintaining hand hygiene, and avoiding crowded places. Amid rising infection numbers, the central government has issued advisories to states and union territories, urging heightened vigilance and preparedness. Healthcare professionals have also stressed the need to differentiate between Covid-19 and other seasonal viral infections, which often present with overlapping symptoms like fever, fatigue, and respiratory issues. Vulnerable individuals—especially senior citizens and those with underlying medical issues—have been advised to exercise caution and seek immediate medical care if symptoms develop or worsen. The Indian Medical Association has reiterated the need for preventive measures, including the use of masks and adherence to hygiene practices, to curb the spread of the virus.
